Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,581.00
(
1.15%
)
US TECH 100
23,548.78
(
1.14%
)
Dow Jones
46,208.47
(
1.38%
)
Brent Oil
96.79
(
-10.49%
)
Bitcoin
70,680.27
(
4.19%
)
News Focus
News Focus
Post# of 257272
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

semi_infinite

Send PM Follow Ignore
Followers 15
Posts 4014
Boards Moderated 1
Alias Born 07/07/2002

semi_infinite

Re: semi_infinite post# 223503

Thursday, 03/14/2019 11:15:46 AM

Thursday, March 14, 2019 11:15:46 AM

Post# of 257272
EYPT - Dexycu (for post cataract surgery inflammation) commercial launch a couple of days ago. ER and CC. Progress as guided.

http://investors.eyepointpharma.com/news-releases/news-release-details/eyepoint-pharmaceuticals-announces-us-commercial-launch-dexycutm

https://edge.media-server.com/m6/p/hz6yprie

Apparently has good visibility on Yutiq uptake via eyepoint-assist program that helps with J-codes and getting insurance coverage, or co-pay assistance.

https://yutiq.com/downloads/YUT00026_EyePoint_Assist_Hub_Enrollment_Form.pdf
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Where Real Traders Talk Markets

Join thousands of traders sharing insights, catalysts, and charts.

Join Today